ASCL2 and colorectal carcinoma: Consistent with the subcutaneous tumorigenesis assay in C57BL/6 mice, downregulation of Ascl2 observably increased the number of tumor-infiltrating CD8+ T cells in primary CRC tumors (Fig. 3J and Supplementary Fig. 4E).